Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Bernd R. Seizinger Insider Profile
4 Followers
Bernd R. Seizinger, Director at Aprea Therapeutics, holds 34.73K shares in Aprea Therapeutics (Ticker: APRE), holds 17.00K shares in Aptose Biosciences (Ticker: APTO).
Profitable Transactions
1 out of 4 Profitable Transactions
Average Return
-35.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Bernd R. Seizinger holds in companies
Most Profitable Insider Trade
The most profitable trade made by Bernd R. Seizinger
Bernd R. Seizinger's Trading History
Aprea Therapeutics
Jun 21, 2024
Director
Uninformative Buy
―
$138.92K
Aptose Biosciences
Sep 25, 2023
Director
Informative Buy
53.38K
$11.22K
List of latest transactions for each holding click on a transaction to see Bernd R. Seizinger's performance on stock
You May Also Like
Bernd R. Seizinger insider profile FAQ
What is the percentage of profitable transactions made by Bernd R. Seizinger?
The percentage of profitable transactions made by Bernd R. Seizinger is 25%.
What is the average return per transaction made by Bernd R. Seizinger?
The average return per transaction made by Bernd R. Seizinger is -35.80%.
What stocks does Bernd R. Seizinger hold?
Bernd R. Seizinger holds: APRE, APTO stocks.
What was Bernd R. Seizinger’s latest transaction?
Bernd R. Seizinger latest transaction was an Uninformative Buy of ―.
What was Bernd R. Seizinger's most profitable transaction?
Bernd R. Seizinger’s most profitable transaction was an Informative Buy of APRE stock on June 8, 2023. The return on the trade was 29.30%.
What is Bernd R. Seizinger's role in Aprea Therapeutics?
Bernd R. Seizinger's role in Aprea Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.